Durable Engraftment, Correction of Genetic Defects and Prevention of Veno-Occlussive Disease, Following Blood and Marrow Transplantation with an HLA-Matched Sibling DONOR, Using a Reduced Toxicity Conditioning Regimen with Busulfan, Reduced Dose Cyclophos

Subjects

Subjects :

Oncology
Transplantation
medicine.medical_specialty
Marrow transplantation
business.industry
Hematology
Disease
Human leukocyte antigen
Reduced dose
Reduced toxicity conditioning
Regimen
Internal medicine
medicine
Sibling
business
Busulfan
medicine.drug

Details

Language :

English

ISSN :

10838791

Issue :

2

Database :

OpenAIRE

Journal :

Biology of Blood and Marrow Transplantation

Accession number :

edsair.doi.dedup.....cdb70948851f85d9cb9d42270c5a266c

Full Text :

https://doi.org/10.1016/j.bbmt.2013.12.103